Erdem Barış Cartı

Erdem Barış Cartı

Auto-generated profile, based on publicly available information

Erdem Barış Cartı

Department of General Surgery, Faculty of Medicine, Aydın Adnan Menderes University, Aydın, Türkiye, 09010, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015
Verified
Journal Article
Closed access
AUAhmet Deniz Uçar
Ahmet Deniz Uçar
EOERKAN OYMACI
ERKAN OYMACI
ECErdem Bariş Carti
Erdem Bariş Carti
SYSavaş Yakan
Savaş Yakan
EVEnver Vardar
Enver Vardar
YMYildirim Mehmet
Yildirim Mehmet

1 January 2020 in Turkish Journal of Trauma and Emergency Surgery
Verified
Journal Article
Open access
ECErdem Barış Cartı
Erdem Barış Cartı
KKKoray Kutlutürk
Koray Kutlutürk
Cholecystectomy is the well-accepted management method for acute cholecystitis in patients suitable for surgery. Percutaneous cholecystostomy is planned and used in patients at high surgical risk due to acute symptomatic cholecystitis and/or acute or chronic comorbidity. Percutaneous cholecystostomy can provide permanent treatment, or it may act as a bridge for elective cholecystectomy. We presented the outcomes of 50 patients who initially underwent ultrasound-guided transhepatic percutaneous cholecystostomy and 4-6 weeks later, an interval cholecystectomy. All patients had either impaired gallbladder wall integrity on contrast-enhanced abdominal computed tomography performed during admission or had grade II acute cholecystitis according to the Tokyo Guidelines 13 diagnostic criteria and severity grading of acute cholecystitis or exhibited clinical signs of acute cholecystitis on the fifth day of non-operative treatment. Our results suggest that although percutaneous cholecystostomy is a useful method for alleviation of the emergency clinical condition in acute cholecystitis, it makes the interval cholecystectomy more difficult to perform due to the dense fibrosis developing during the healing process, eventually complicating laparoscopic cholecystectomy. Cholecystostomy may cause fibrosis during the healing process, eventually complicating laparoscopic cholecystectomy. Thus, there is a need for better evaluation during the identification of indications for cholecystostomy.

3 November 2014 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
ECErdem Baris Carti
Erdem Baris Carti
EOERKAN OYMACI
ERKAN OYMACI
AUAhmet Deniz Ucar
Ahmet Deniz Ucar
ACAli Coskun
Ali Coskun
NENazif Erkan
Nazif Erkan
MYMehmet Yildirim
Mehmet Yildirim

1 January 2025 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
OAOgün Aydoğan
Ogün Aydoğan
MCMuhammed Çağrı Coşkun
Muhammed Çağrı Coşkun
UŞUlaş Utku Şekerci
Ulaş Utku Şekerci
ECErdem Barış Cartı
Erdem Barış Cartı
Aydoğan O, et al. Ann Surg Treat Res. 2025 Feb;108(2):79-85. https://doi.org/10.4174/astr.2025.108.2.79

1 January 2019 in International Surgery
Verified
Journal Article
Open access
MÜMutlu Ünver
Mutlu Ünver
EKEyüp Kebapçı
Eyüp Kebapçı
MGMurat Guner
Murat Guner
ŞÖŞafak Öztürk
Şafak Öztürk
VEVarlık Erol
Varlık Erol
GAGökhan Akbulut
Gökhan Akbulut
Fournier gangrene is described as necrotizing fasciitis involving the genital, perineal, and perianal area. Early surgical debridement of necrotic tissues, topical therapy, and antibiotics are fundamental in the treatment of Fournier gangrene. We aimed to compare the effects of Dakin solution and povidone iodine solution on patient outcomes by using the Fournier gangrene severity index (FGSI). The demographic data, comorbid diseases, local therapeutic interventions, FGSI, necessity of diverting colostomy or orchiectomy, hospitalization time, number of debridements, complications, and outcomes of 57 patients with Fournier gangrene were retrospectively analyzed. A total of 47 of 57 patients (82.5%) were male, and 10 patients (17.5%) were female, with a mean age of 62.3 ± 13.8 years (range, 27–85 years). The survivors were significantly younger than the nonsurvivors. The mean FGSI score was 4 (range, 1–9) in survivors, and mean FGSI score was 9 (range, 6–10) in nonsurvivors. FGSI score was significantly higher in the mortality group. The median hospital stay was 13 days (range, 3–34 days) in the Dakin solution group and 20 days (range, 1–41 days) in the povidone iodine group. Overall mortality rate was 17.5%. Advanced age had a statistically significant effect on mortality. The hospitalization time was significantly shorter in the Dakin solution group, and use of Dakin solution decreased the number of debridements. Dakin solution has favorable effects on hospital stay and the necessity of multiple debridements. Dakin solution seems to be a good and cost-effective choice for treatment in local wound healing.

8 March 2017 in Turkish Journal of Colorectal Disease
Verified
Journal Article
Open access
EYEyüp Murat Yılmaz
Eyüp Murat Yılmaz
ECErdem Barış Cartı
Erdem Barış Cartı
MGMustafa Gok
Mustafa Gok
HÖHedef Özgün
Hedef Özgün